Radcliffe Capital Management, L.P. - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 12 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$100,279,000
+44.6%
100,783,000
+42.4%
6.28%
+0.1%
Q3 2020$69,363,000
+137.6%
70,783,000
+134.8%
6.27%
+56.6%
Q2 2020$29,198,000
+99.4%
30,151,000
+90.6%
4.00%
+45.5%
Q1 2020$14,645,00015,823,0002.75%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q1 2021
NameSharesValueWeighting ↓
Western Asset Management Company, LLC 18,321,000$16,718,0009.03%
INCOME RESEARCH & MANAGEMENT 15,589,000$14,000,0006.80%
WHITEBOX ADVISORS LLC 16,000,000$14,487,0000.53%
Graham Capital Management, L.P. 16,525,000$15,005,0000.49%
ONTARIO TEACHERS PENSION PLAN BOARD 18,400,000$16,752,0000.30%
WESTWOOD HOLDINGS GROUP INC 29,005,000$26,516,0000.29%
Penn Capital Management Company, LLC 2,195,000$1,987,0000.21%
ADVENT CAPITAL MANAGEMENT /DE/ 10,000,000$9,128,0000.17%
Polar Capital LLP 20,663,000$18,813,0000.17%
RIVERHEAD CAPITAL MANAGEMENT LLC 5,000,000$4,529,0000.17%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders